Teva Overview

  • View
    217

  • Download
    3

Embed Size (px)

Text of Teva Overview

  • 1

    Teva introduction Teva introduction

    2014

  • 2

  • Our Vision

    Being the most indispensable

    medicines company for the world,

    executing on our obligation to

    our patients, customers,

    shareholders and employees

  • We have Profound Foundations

    45,000 employees

    73 manufacturing

    sites

    111 years in

    existence

    1,000 molecules

    60 countries

    73B tablets and

    capsules per annum

    55,000+ SKUs

    $5.01 2013 EPS

    $20.3B 2013 revenues

  • Core Strengths

    Leading healthcare provider

    Balanced business

    model

    Integrated

    R&D

    Manufacturing strengths

    Partnering experience

    Go-to-market capabilities

    Entrepreneurial employees and

    culture

  • A truly global operations network

  • Financial Growth

    * Operating income and net income are non-GAAP results

    2013 2012

    20,314 20,317 Sales $M

    5,198 5,715 Operating Income $M

    4,255 4,671 Net Income $M

  • Expansion of wealth and health care access

    Rising health care costs

    Our World Changes

    Aging population

    Increasing competition in generics

    Shift in disease patterns

    Rising bar for product innovation

    Complicated, expanding global market

  • Branded generics business

    R&D capabilities

    Impact healthcare system

    Pipeline of high-value products

    Generics: a great future

    Global

    Sustainable high-barrier to entry

    Rapid growth

    Dramatically enhanced in selected areas

  • Research and development

    Develop the most competitive

    and focused pipeline

    to address unmet patient needs

    in a highly differentiated way

    to drive the growth of Teva

    Life and science intimately connected thats uniquely Teva

  • NTEs High value

    generics

    Focused specialty portfolio

    NTEs - The Future of Teva R&D

    NEW THERAPEUTIC ENTITY Known molecule that is formulated, delivered, or used in a novel way to

    address specific patient needs

  • Specialty medicines: focus and build leadership

    CNS

    Respiratory

    New Therapeutic Entities (NTEs)

    Oncology, Women's Health, Biologics

    Protect and expand MS franchise

    Build products and pipeline

    Invest in capabilities and pipeline

    Continue global expansion

    Capitalize on unique Teva interface

    of Generics and Specialty

    Selectively invest

  • 17 17

    OTC Business

    Worlds leading provider of medicines Portfolio of leading brands

    Best-in-class

    Consumer understanding

    Brand-building

    Advertising scale

    Strong product development and

    production capabilities Worlds leading brand-

    builder

    +

    PGT Consumer Healthcare: JV with P&G leverages value in existing OTC business

  • 18

    Teva Global Community Statement

    Teva is committed to improving global healthcare. We recognize our responsibility to invest in and support the communities we serve.

    We focus our involvement on the communities in the countries in which we operate, through a range of activities that enhance access to medicines and contribute to the wellbeing of the communities in which we live.

    We are proud of our many employees who volunteer in the community and we support them in a range of ways.

  • 19

  • 20